Curated News
By: NewsRamp Editorial Staff
November 02, 2026
SS Innovations Demonstrates Long-Distance Robotic Cardiac Surgery
TLDR
- SS Innovations' SSi Mantra enables remote cardiac surgery over 7,500 miles, positioning the company ahead in telesurgery as it targets FDA clearance in Q1 2027.
- The SSi Mantra system and MantrAsana console allow surgeons to perform robotic procedures remotely; 205 telesurgeries have been completed as of October 23, 2026.
- Remote robotic surgery can extend specialist care to underserved areas, potentially making advanced surgical expertise accessible beyond major medical centers.
- During October 2026 conferences, SS Innovations demonstrated a robotic-assisted atrial septal defect procedure performed from Barcelona on a patient in Bengaluru, India.
Impact - Why it Matters
The successful demonstration of remote robotic cardiac surgery signals a major step toward democratizing access to specialized surgical expertise. By enabling surgeons to operate on patients thousands of miles away, this technology could bring advanced care to underserved regions and reduce the need for patient travel. However, widespread adoption will depend on clinical validation, reliable connectivity, and regulatory approvals, such as the pending FDA clearance for the SSi Mantra. This news matters because it showcases a potential paradigm shift in how surgical care is delivered, with implications for healthcare accessibility and patient outcomes worldwide.
Summary
SS Innovations (NASDAQ: SSII), a developer of innovative surgical robotic technologies, showcased its SSi Mantra surgical robotic system and SSi MantrAsana tele-surgeon console at two international medical conferences in October 2026. At the 40th European Association for Cardio-Thoracic Surgery (EACTS) annual meeting in Barcelona, Chairman and CEO Dr. Sudhir Srivastava performed a robotic-assisted atrial septal defect procedure on a patient located approximately 7,500 miles away in Bengaluru, India. The demonstration highlighted the potential of remote robotic surgery to bridge geographic gaps in specialized care.
In addition, four other robotic telesurgeries were performed or broadcast during the inaugural Society of Robotic Surgery India conference, covering urological, colorectal, pediatric and gynecological procedures. The company reported that as of October 23, 2026, 205 telesurgeries have been performed using the SSi Mantra system, including cardiac procedures. These events underscore SS Innovations’ commitment to advancing tele-surgery and expanding access to expert surgical care. The company is also pursuing U.S. Food and Drug Administration clearance for the SSi Mantra, with completion of the 510(k) review targeted for the first quarter of 2027, subject to the FDA’s review. For more details, Read More.
Source Statement
This curated news summary relied on content distributed by NewMediaWire. Read the original source here, SS Innovations Demonstrates Long-Distance Robotic Cardiac Surgery
